Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 854070, 10 pages
http://dx.doi.org/10.1155/2015/854070
Review Article

Kidney Injury Molecule-1 and Cardiovascular Diseases: From Basic Science to Clinical Practice

1Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Dr Subotica Starijeg 1, 11129 Belgrade, Serbia
2Center for Endocrine Surgery, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Koste Todorovica 8, 11000 Belgrade, Serbia
3Department of Pathology, Faculty of Medicine, University of Belgrade, Dr Subotica Starijeg 1, 11129 Belgrade, Serbia

Received 24 July 2015; Revised 27 October 2015; Accepted 4 November 2015

Academic Editor: Hua Zhue

Copyright © 2015 Branislava Medić et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Bellomo, C. Ronco, J. A. Kellum, R. L. Mehta, and P. Palevsky, “Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) group,” Critical Care, vol. 8, pp. R204–R212, 2004. View at Publisher · View at Google Scholar
  2. S. Uchino, J. A. Kellum, R. Bellomo et al., “Acute renal failure in critically ill patients: a multinational, multicenter study,” The Journal of the American Medical Association, vol. 294, no. 7, pp. 813–818, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. E. A. J. Hoste, G. Clermont, A. Kersten et al., “RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis,” Critical Care, vol. 10, no. 3, article R73, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Z. Ali, I. Khan, W. Simpson et al., “Incidence and outcomes in acute kidney injury: a comprehensive population-based study,” Journal of the American Society of Nephrology, vol. 18, no. 4, pp. 1292–1298, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Bellomo, J. A. Kellum, and C. Ronco, “Defining acute renal failure: physiological principles,” Intensive Care Medicine, vol. 30, no. 1, pp. 33–37, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. S. G. Coca and C. R. Parikh, “Urinary biomarkers for acute kidney injury: perspectives on translation,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 2, pp. 481–490, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. C. L. Dent, Q. Ma, S. Dastrala et al., “Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study,” Critical Care, vol. 11, no. 6, article R127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Atkinson A.J., W. A. Colburn, V. G. DeGruttola et al., “Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework,” Clinical Pharmacology and Therapeutics, vol. 69, no. 3, pp. 89–95, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Singhal and A. Saha, “Bedside biomarkers in pediatric cardio renal injuries in emergency,” International Journal of Critical Illness and Injury Science, vol. 4, no. 3, pp. 238–246, 2014. View at Publisher · View at Google Scholar
  10. S. S. Soni, C. Ronco, N. Katz, and D. N. Cruz, “Early diagnosis of acute kidney injury: the promise of novel biomarkers,” Blood Purification, vol. 28, no. 3, pp. 165–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Ichimura, C. C. Hung, S. A. Yang, J. L. Stevens, and J. V. Bonventre, “Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury,” American Journal of Physiology—Renal Physiology, vol. 286, no. 3, pp. F552–F563, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. V. S. Vaidya, V. Ramirez, T. Ichimura, N. A. Bobadilla, and J. V. Bonventre, “Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury,” The American Journal of Physiology—Renal Physiology, vol. 290, no. 2, pp. F517–F529, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Ichimura, J. V. Bonventre, V. Bailly et al., “Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury,” Journal of Biological Chemistry, vol. 273, no. 7, pp. 4135–4142, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Ichimura, C. R. Brooks, and J. V. Bonventre, “Kim-1/Tim-1 and immune cells: shifting sands,” Kidney International, vol. 81, no. 9, pp. 809–811, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Ichimura, E. J. P. V. Asseldonk, B. D. Humphreys, L. Gunaratnam, J. S. Duffield, and J. V. Bonventre, “Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells,” The Journal of Clinical Investigation, vol. 118, no. 5, pp. 1657–1668, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. W. K. Han, V. Bailly, R. Abichandani, R. Thadhani, and J. V. Bonventre, “Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury,” Kidney International, vol. 62, no. 1, pp. 237–244, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Ferguson, V. S. Vaidya, and J. V. Bonventre, “Biomarkers of nephrotoxic acute kidney injury,” Toxicology, vol. 245, no. 3, pp. 182–193, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Bailly, Z. Zhang, W. Meier, R. Cate, M. Sanicola, and J. V. Bonventre, “Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration,” The Journal of Biological Chemistry, vol. 277, no. 42, pp. 39739–39748, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Devarajan, “The future of pediatric AKI management biomarkers,” Seminars in Nephrology, vol. 28, no. 5, pp. 493–498, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. H. L. Hillege, D. Nitsch, M. A. Pfeffer et al., “Renal function as a predictor of outcome in a broad spectrum of patients with heart failure,” Circulation, vol. 113, no. 5, pp. 671–678, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Feigelstock, P. Thompson, P. Mattoo, Y. Zhang, and G. G. Kaplan, “The human homolog of HAVcr-1 codes for a hepatitis a virus cellular receptor,” Journal of Virology, vol. 72, no. 8, pp. 6621–6628, 1998. View at Google Scholar · View at Scopus
  22. M. M. van Timmeren, M. C. van den Heuvel, V. Bailly, S. J. L. Bakker, H. van Goor, and C. A. Stegeman, “Tubular kidney injury molecule-1 (KIM-1) in human renal disease,” The Journal of Pathology, vol. 212, no. 2, pp. 209–217, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. V. Bonventre, “Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more,” Nephrology Dialysis Transplantation, vol. 24, no. 11, pp. 3265–3268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Di Tommaso, S. Moretti, I. Xenarios et al., “T-Coffee: a web server for the multiple sequence alignment of protein and RNA sequences using structural information and homology extension,” Nucleic Acids Research, vol. 39, no. 2, pp. W13–W17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. F. Altschul, T. L. Madden, A. A. Schäffer et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Research, vol. 25, no. 17, pp. 3389–3402, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Todorović, B. Medić, G. Basta-Jovanović et al., “Acute pretreatment with chloroquine attenuates renal I/R injury in rats,” PLoS ONE, vol. 9, no. 3, Article ID e92673, 2014. View at Publisher · View at Google Scholar
  27. B. D. Humphreys, V. S. Vaidya, R. Samarakoon, D. M. Hentschel, K. M. Park, and J. V. Bonventre, “Early and sustained expression of kidney injury molecule-1 (Kim-1) after unilateral ureteral obstruction,” Journal of the American Society of Nephrology, vol. 16, p. 425A, 2005. View at Google Scholar
  28. W. C. Prozialeck, V. S. Vaidya, J. Liu et al., “Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity,” Kidney International, vol. 72, no. 8, pp. 985–993, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Zhou, V. S. Vaidya, R. P. Brown et al., “Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium,” Toxicological Sciences, vol. 101, no. 1, pp. 159–170, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. L. Slocum, M. Heung, and S. Pennathur, “Marking renal injury: can we move beyond serum creatinine?” Translational Research, vol. 159, no. 4, pp. 277–289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. V. S. Sabbisetti, K. Ito, C. Wang, L. Yang, S. C. Mefferd, and J. V. Bonventre, “Novel assays for detection of urinary KIM-1 in mouse models of kidney injury,” Toxicological Sciences, vol. 131, no. 1, pp. 13–25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. A. B. Kramer, M. M. van Timmeren, T. A. Schuurs et al., “Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time,” American Journal of Physiology—Renal Physiology, vol. 296, no. 5, pp. F1136–F1145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Mårtensson, C.-R. Martling, and M. Bell, “Novel biomarkers of acute kidney injury and failure: clinical applicability,” British Journal of Anaesthesia, vol. 109, no. 6, pp. 843–850, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Dieterle, F. Sistare, F. Goodsaid et al., “Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium,” Nature Biotechnology, vol. 28, no. 5, pp. 455–462, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. O. Liangos, M. C. Perianayagam, V. S. Vaidya et al., “Urinary N-acetyl-β(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure,” Journal of the American Society of Nephrology, vol. 18, no. 3, pp. 904–912, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. S. G. Coca, R. Yalavarthy, J. Concato, and C. R. Parikh, “Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review,” Kidney International, vol. 73, no. 9, pp. 1008–1016, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. V. S. Vaidya, G. M. Ford, S. S. Waikar et al., “A rapid urine test for early detection of kidney injury,” Kidney International, vol. 76, no. 1, pp. 108–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. Z. Todorović, M. Prostran, Z. Nešić, R. Stojanović, and M. Stojanov, “The influence of drugs on biochemical markers of ischemia-reperfusion injury,” in The Analysis of Pharmacologically Active Compounds and Biomolecules in Real Samples, R. Injac, Ed., pp. 217–238, Transworld Research Network, Kerala, India, 2009. View at Google Scholar
  39. E. Tsigou, V. Psallida, C. Demponeras, E. Boutzouka, and G. Baltopoulos, “Role of new biomarkers: functional and structural damage,” Critical Care Research and Practice, vol. 2013, Article ID 361078, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Lucarelli, V. Mancini, V. Galleggiante et al., “Emerging urinary markers of renal injury in obstructive nephropathy,” BioMed Research International, vol. 2014, Article ID 303298, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Lucarelli, P. Ditonno, C. Bettocchi et al., “Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma,” Disease Markers, vol. 2014, Article ID 689795, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. S. R. Lee and K. H. Jeong, “Novel biomarkers for cardio-renal syndrome,” Electrolyte and Blood Pressure, vol. 10, no. 1, pp. 12–17, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Aronson, “Cardiorenal syndrome in acute decompensated heart failure,” Expert Review of Cardiovascular Therapy, vol. 10, no. 2, pp. 177–189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. S. S. Gottlieb, W. Abraham, J. Butler et al., “The prognostic importance of different definitions of worsening renal function in congestive heart failure,” Journal of Cardiac Failure, vol. 8, no. 3, pp. 136–141, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. D. E. Forman, J. Butler, Y. Wang et al., “Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure,” Journal of the American College of Cardiology, vol. 43, no. 1, pp. 61–67, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. National Kidney Foundation, “K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” American Journal of Kidney Diseases, vol. 39, pp. S1–S266, 2002. View at Google Scholar
  47. J. T. Heywood, G. C. Fonarow, M. R. Costanzo, V. S. Mathur, J. R. Wigneswaran, and J. Wynne, “High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database,” Journal of Cardiac Failure, vol. 13, no. 6, pp. 422–430, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Tonelli, N. Wiebe, B. Culleton et al., “Chronic kidney disease and mortality risk: a systematic review,” Journal of the American Society of Nephrology, vol. 17, no. 7, pp. 2034–2047, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Hawkins, “New biomarkers of acute kidney injury and the cardio-renal syndrome,” Korean Journal of Laboratory Medicine, vol. 31, no. 2, pp. 72–80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Damman, S. Masson, H. L. Hillege et al., “Clinical outcome of renal tubular damage in chronic heart failure,” European Heart Journal, vol. 32, no. 21, pp. 2705–2712, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Ghatanatti, A. Teli, S. S. Tirkey, S. Bhattacharya, G. Sengupta, and A. Mondal, “Role of renal biomarkers as predictors of acute kidney injury in cardiac surgery,” Asian Cardiovascular and Thoracic Annals, vol. 22, no. 2, pp. 234–241, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Bellomo, S. Auriemma, A. Fabbri et al., “The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI),” International Journal of Artificial Organs, vol. 31, no. 2, pp. 166–178, 2008. View at Google Scholar · View at Scopus
  53. K. Karkouti, D. N. Wijeysundera, T. M. Yau et al., “Acute kidney injury after cardiac surgery: focus on modifiable risk factors,” Circulation, vol. 119, no. 4, pp. 495–502, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Lassnigg, D. Schmidlin, M. Mouhieddine et al., “Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study,” Journal of the American Society of Nephrology, vol. 15, no. 6, pp. 1597–1605, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Mao, N. Katz, W. Ariyanon et al., “Cardiac surgery-associated acute kidney injury,” CardioRenal Medicine, vol. 3, no. 3, pp. 178–199, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Haase, R. Bellomo, and A. Haase-Fielitz, “Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury,” Journal of the American College of Cardiology, vol. 55, no. 19, pp. 2024–2033, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Kolli, S. Rajagopalam, N. Patel et al., “Mild acute kidney injury is associated with increased mortality after cardiac surgery in patients with eGFR < 60 mL/min/1.73 m2,” Renal Failure, vol. 32, no. 9, pp. 1066–1072, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Mishra, C. Dent, R. Tarabishi et al., “Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery,” The Lancet, vol. 365, no. 9466, pp. 1231–1238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. O. Liangos, W. K. Han, R. Wald et al., “Urinary kidney injury molecule-1 level is an early and sensitive marker of acute kidney injury [Abstract],” Journal of the American Society of Nephrology, vol. 17, p. 403A, 2006. View at Google Scholar
  60. W. K. Han, S. S. Waikar, A. Johnson, G. C. Curhan, P. Devarajan, and J. V. Bonventre, “Urinary biomarkers for early detection of acute kidney injury [Abstract],” Journal of the American Society of Nephrology, vol. 17, article 403A, 2006. View at Google Scholar
  61. C. Hudson, J. Hudson, M. Swaminathan, A. Shaw, M. Stafford-Smith, and U. D. Patel, “Emerging concepts in acute kidney injury following cardiac surgery,” Seminars in Cardiothoracic and Vascular Anesthesia, vol. 12, no. 4, pp. 320–330, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. J. L. Koyner, V. S. Vaidya, M. R. Bennett et al., “Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 12, pp. 2154–2165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. I. E. Hall, S. G. Coca, M. A. Perazella et al., “Risk of poor outcomes with novel and traditional biomarkers at clinical AKI diagnosis,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 12, pp. 2740–2749, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. J. M. Arthur, E. G. Hill, J. L. Alge et al., “Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery,” Kidney International, vol. 85, no. 2, pp. 431–438, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. W. K. Han, G. Wagener, Y. Zhu, S. Wang, and H. T. Lee, “Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 5, pp. 873–882, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. E. Abdallah, E. Waked, B. Al-Helal, R. Asad, M. Nabil, and T. Harba, “Novel troponin-like biomarkers of acute kidney injury,” Saudi Journal of Kidney Diseases and Transplantation, vol. 24, no. 6, pp. 1111–1124, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. W. K. Han, S. S. Waikar, A. Johnson et al., “Urinary biomarkers in the early diagnosis of acute kidney injury,” Kidney International, vol. 73, no. 7, pp. 863–869, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. C. D. Krawczeski, J. G. Woo, Y. Wang, M. R. Bennett, Q. Ma, and P. Devarajan, “Neutrophil gelatinase-associated lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass,” The Journal of Pediatrics, vol. 158, no. 6, pp. 1009.e1–1015.e1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. M. A. Hazle, R. J. Gajarski, R. Aiyagari et al., “Urinary biomarkers and renal near-infrared spectroscopy predict intensive care unit outcomes after cardiac surgery in infants younger than 6 months of age,” Journal of Thoracic and Cardiovascular Surgery, vol. 146, no. 4, pp. 861.e1–867.e1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. H. L. Hillege, W. H. van Gilst, D. J. van Veldhuisen et al., “Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial,” European Heart Journal, vol. 24, no. 5, pp. 412–420, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. C. R. Parikh, S. G. Coca, Y. Wang, F. A. Masoudi, and H. M. Krumholz, “Long-term prognosis of acute kidney injury after acute myocardial infarction,” Archives of Internal Medicine, vol. 168, no. 9, pp. 987–995, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Goldberg, E. Kogan, H. Hammerman, W. Markiewicz, and D. Aronson, “The impact of transient and persistent acute kidney injury on long-term outcomes after acute myocardial infarction,” Kidney International, vol. 76, no. 8, pp. 900–906, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. A. A. Eddy, “Molecular basis of renal fibrosis,” Pediatric Nephrology, vol. 15, no. 3-4, pp. 290–301, 2000. View at Publisher · View at Google Scholar · View at Scopus
  74. N. G. Frangogiannis, “The immune system and cardiac repair,” Pharmacological Research, vol. 58, no. 2, pp. 88–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Nian, P. Lee, N. Khaper, and P. Liu, “Inflammatory cytokines and postmyocardial infarction remodeling,” Circulation Research, vol. 94, no. 12, pp. 1543–1553, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. H. J. Dargie, H. M. McAlpine, and J. J. Morton, “Neuroendocrine activation in acute myocardial infarction,” Journal of Cardiovascular Pharmacology, vol. 9, no. 2, pp. S21–S24, 1987. View at Publisher · View at Google Scholar · View at Scopus
  77. D. Fraccarollo, P. Galuppo, S. Hildemann, M. Christ, G. Ertl, and J. Bauersachs, “Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction,” Journal of the American College of Cardiology, vol. 42, no. 9, pp. 1666–1673, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. L. McDonald, C. Baker, C. Bray, A. McDonald, and N. Restieaux, “Plasma-catecholamines after cardiac infarction,” The Lancet, vol. 2, no. 7629, pp. 1021–1023, 1969. View at Google Scholar · View at Scopus
  79. H. Persson, K. Andréasson, T. Kahan et al., “Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists,” European Journal of Heart Failure, vol. 4, no. 1, pp. 73–82, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. S. Lekawanvijit, A. R. Kompa, Y. Zhang, B. H. Wang, D. J. Kelly, and H. Krum, “Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 302, no. 9, pp. H1884–H1893, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Halawa, “The early diagnosis of acute renal graft dysfunction: a challenge we face. The role of novel biomarkers,” Annals of Transplantation, vol. 16, no. 1, pp. 90–98, 2011. View at Google Scholar · View at Scopus
  82. D. N. Cruz, H. R. de Geus, and S. M. Bagshaw, “Biomarker strategies to predict need for renal replacement therapy in acute kidney injury,” Seminars in Dialysis, vol. 24, no. 2, pp. 124–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. W. N. Nijboer, T. A. Schuurs, J. Damman et al., “Kidney injury molecule-1 is an early noninvasive indicator for donor brain death-induced injury prior to kidney transplantation,” American Journal of Transplantation, vol. 9, no. 8, pp. 1752–1759, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. B. Schröppel, B. Krüger, L. Walsh et al., “Tubular expression of KIM-1 does not predict delayed function after transplantation,” Journal of the American Society of Nephrology, vol. 21, no. 3, pp. 536–542, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. C.-C. Szeto, B. C.-H. Kwan, K.-B. Lai et al., “Urinary expression of kidney injury markers in renal transplant recipients,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 12, pp. 2329–2337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. P. W. Peake, T. J. Pianta, L. Succar et al., “A comparison of the ability of levels of urinary biomarker proteins and exosomal mRNA to predict outcomes after renal transplantation,” PLoS ONE, vol. 9, no. 6, Article ID e98644, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. T. J. Pianta, P. W. Peake, J. W. Pickering, M. Kelleher, N. A. Buckley, and Z. H. Endre, “Clusterin in kidney transplantation: novel biomarkers versus serum creatinine for early prediction of delayed graft function,” Transplantation, vol. 99, no. 1, pp. 171–179, 2015. View at Publisher · View at Google Scholar · View at Scopus
  88. U. Kunzendorf, M. Haase, L. Rölver, and A. Haase-Fielitz, “Novel aspects of pharmacological therapies for acute renal failure,” Drugs, vol. 70, no. 9, pp. 1099–1114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Kokkoris, C. Pipili, E. Grapsa, T. Kyprianou, and S. Nanas, “Novel biomarkers of acute kidney injury in the general adult ICU: a review,” Renal Failure, vol. 35, no. 4, pp. 579–591, 2013. View at Publisher · View at Google Scholar · View at Scopus
  90. F. Gonzalez and F. Vincent, “Biomarkers for acute kidney injury in critically ill patients,” Minerva Anestesiologica, vol. 78, no. 12, pp. 1394–1403, 2012. View at Google Scholar · View at Scopus
  91. Z. H. Endre, J. W. Pickering, R. J. Walker et al., “Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function,” Kidney International, vol. 79, no. 10, pp. 1119–1130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. G. L. Smith, J. H. Lichtman, M. B. Bracken et al., “Renal impairment and outcomes in heart failure: systematic review and meta-analysis,” Journal of the American College of Cardiology, vol. 47, no. 10, pp. 1987–1996, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. Z. H. Endre and J. W. Pickering, “Biomarkers and creatinine in AKI: the trough of disillusionment or the slope of enlightenment?” Kidney International, vol. 84, no. 4, pp. 644–647, 2013. View at Publisher · View at Google Scholar · View at Scopus